2025-04-012026-03-312026-03-31false069561694A DENTAL SURGERY LTD2026-07-01falseiso4217:GBPxbrli:pure069561692025-03-31069561692026-03-31069561692025-04-012026-03-31069561692024-03-31069561692025-03-31069561692024-04-012025-03-3106956169bus:SmallEntities2025-04-012026-03-3106956169bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3106956169bus:FullAccounts2025-04-012026-03-3106956169bus:PrivateLimitedCompanyLtd2025-04-012026-03-3106956169core:WithinOneYear2026-03-3106956169core:AfterOneYear2026-03-3106956169core:WithinOneYear2025-03-3106956169core:AfterOneYear2025-03-3106956169core:ShareCapital2026-03-3106956169core:SharePremium2026-03-3106956169core:RevaluationReserve2026-03-3106956169core:OtherReservesSubtotal2026-03-3106956169core:RetainedEarningsAccumulatedLosses2026-03-3106956169core:ShareCapital2025-03-3106956169core:SharePremium2025-03-3106956169core:RevaluationReserve2025-03-3106956169core:OtherReservesSubtotal2025-03-3106956169core:RetainedEarningsAccumulatedLosses2025-03-3106956169core:LandBuildings2026-03-3106956169core:PlantMachinery2026-03-3106956169core:Vehicles2026-03-3106956169core:FurnitureFittings2026-03-3106956169core:OfficeEquipment2026-03-3106956169core:NetGoodwill2026-03-3106956169core:IntangibleAssetsOtherThanGoodwill2026-03-3106956169core:ListedExchangeTraded2026-03-3106956169core:UnlistedNon-exchangeTraded2026-03-3106956169core:LandBuildings2025-03-3106956169core:PlantMachinery2025-03-3106956169core:Vehicles2025-03-3106956169core:FurnitureFittings2025-03-3106956169core:OfficeEquipment2025-03-3106956169core:NetGoodwill2025-03-3106956169core:IntangibleAssetsOtherThanGoodwill2025-03-3106956169core:ListedExchangeTraded2025-03-3106956169core:UnlistedNon-exchangeTraded2025-03-3106956169core:LandBuildings2025-04-012026-03-3106956169core:PlantMachinery2025-04-012026-03-3106956169core:Vehicles2025-04-012026-03-3106956169core:FurnitureFittings2025-04-012026-03-3106956169core:OfficeEquipment2025-04-012026-03-3106956169core:NetGoodwill2025-04-012026-03-3106956169core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3106956169core:ListedExchangeTraded2025-04-012026-03-3106956169core:UnlistedNon-exchangeTraded2025-04-012026-03-3106956169core:MoreThanFiveYears2025-04-012026-03-3106956169core:Non-currentFinancialInstruments2026-03-3106956169core:Non-currentFinancialInstruments2025-03-3106956169dpl:CostSales2025-04-012026-03-3106956169dpl:DistributionCosts2025-04-012026-03-3106956169core:LandBuildings2025-04-012026-03-3106956169core:PlantMachinery2025-04-012026-03-3106956169core:Vehicles2025-04-012026-03-3106956169core:FurnitureFittings2025-04-012026-03-3106956169core:OfficeEquipment2025-04-012026-03-3106956169dpl:AdministrativeExpenses2025-04-012026-03-3106956169core:NetGoodwill2025-04-012026-03-3106956169core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3106956169dpl:GroupUndertakings2025-04-012026-03-3106956169dpl:ParticipatingInterests2025-04-012026-03-3106956169dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3106956169core:ListedExchangeTraded2025-04-012026-03-3106956169dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3106956169core:UnlistedNon-exchangeTraded2025-04-012026-03-3106956169dpl:CostSales2024-04-012025-03-3106956169dpl:DistributionCosts2024-04-012025-03-3106956169core:LandBuildings2024-04-012025-03-3106956169core:PlantMachinery2024-04-012025-03-3106956169core:Vehicles2024-04-012025-03-3106956169core:FurnitureFittings2024-04-012025-03-3106956169core:OfficeEquipment2024-04-012025-03-3106956169dpl:AdministrativeExpenses2024-04-012025-03-3106956169core:NetGoodwill2024-04-012025-03-3106956169core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106956169dpl:GroupUndertakings2024-04-012025-03-3106956169dpl:ParticipatingInterests2024-04-012025-03-3106956169dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3106956169core:ListedExchangeTraded2024-04-012025-03-3106956169dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3106956169core:UnlistedNon-exchangeTraded2024-04-012025-03-3106956169core:NetGoodwill2026-03-3106956169core:IntangibleAssetsOtherThanGoodwill2026-03-3106956169core:LandBuildings2026-03-3106956169core:PlantMachinery2026-03-3106956169core:Vehicles2026-03-3106956169core:FurnitureFittings2026-03-3106956169core:OfficeEquipment2026-03-3106956169core:AfterOneYear2026-03-3106956169core:WithinOneYear2026-03-3106956169core:ListedExchangeTraded2026-03-3106956169core:UnlistedNon-exchangeTraded2026-03-3106956169core:ShareCapital2026-03-3106956169core:SharePremium2026-03-3106956169core:RevaluationReserve2026-03-3106956169core:OtherReservesSubtotal2026-03-3106956169core:RetainedEarningsAccumulatedLosses2026-03-3106956169core:NetGoodwill2025-03-3106956169core:IntangibleAssetsOtherThanGoodwill2025-03-3106956169core:LandBuildings2025-03-3106956169core:PlantMachinery2025-03-3106956169core:Vehicles2025-03-3106956169core:FurnitureFittings2025-03-3106956169core:OfficeEquipment2025-03-3106956169core:AfterOneYear2025-03-3106956169core:WithinOneYear2025-03-3106956169core:ListedExchangeTraded2025-03-3106956169core:UnlistedNon-exchangeTraded2025-03-3106956169core:ShareCapital2025-03-3106956169core:SharePremium2025-03-3106956169core:RevaluationReserve2025-03-3106956169core:OtherReservesSubtotal2025-03-3106956169core:RetainedEarningsAccumulatedLosses2025-03-3106956169core:NetGoodwill2024-03-3106956169core:IntangibleAssetsOtherThanGoodwill2024-03-3106956169core:LandBuildings2024-03-3106956169core:PlantMachinery2024-03-3106956169core:Vehicles2024-03-3106956169core:FurnitureFittings2024-03-3106956169core:OfficeEquipment2024-03-3106956169core:AfterOneYear2024-03-3106956169core:WithinOneYear2024-03-3106956169core:ListedExchangeTraded2024-03-3106956169core:UnlistedNon-exchangeTraded2024-03-3106956169core:ShareCapital2024-03-3106956169core:SharePremium2024-03-3106956169core:RevaluationReserve2024-03-3106956169core:OtherReservesSubtotal2024-03-3106956169core:RetainedEarningsAccumulatedLosses2024-03-3106956169core:AfterOneYear2025-04-012026-03-3106956169core:WithinOneYear2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3106956169core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3106956169core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3106956169core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3106956169core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3106956169core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3106956169core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3106956169core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3106956169core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3106956169core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3106956169core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3106956169core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3106956169core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3106956169core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3106956169core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3106956169core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3106956169core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3106956169core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3106956169core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3106956169bus:Director12025-04-012026-03-3106956169core:FurnitureFittingsToolsEquipment2025-03-3106956169core:FurnitureFittingsToolsEquipment2025-04-012026-03-3106956169core:FurnitureFittingsToolsEquipment2026-03-31

4A DENTAL SURGERY LTD

Registered Number
06956169
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

4A DENTAL SURGERY LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Director

Dr John Booth

Company Secretary

Mrs Keely Booth

Registered Address

Fulford Lodge
1 Heslington Lane
York
YO10 4HW

Registered Number

06956169 (England and Wales)
4A DENTAL SURGERY LTD
Statement of Financial Position
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets392,05092,050
Tangible assets421,62318,651
113,673110,701
Current assets
Stocks51,7801,780
Debtors621,06341,698
Cash at bank and on hand50,42950,654
73,27294,132
Creditors amounts falling due within one year7(61,159)(98,565)
Net current assets (liabilities)12,113(4,433)
Total assets less current liabilities125,786106,268
Creditors amounts falling due after one year8-(7,538)
Net assets125,78698,730
Capital and reserves
Called up share capital22
Profit and loss account125,78498,728
Shareholders' funds125,78698,730
The financial statements were approved and authorised for issue by the Director on 1 July 2026, and are signed on its behalf by:
Dr John Booth
Director
Registered Company No. 06956169
4A DENTAL SURGERY LTD
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Plant and machinery15
Office Equipment25
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Stocks and work in progress
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all cost of purchase, cost of conversion and other costs incurred in bringing the stock to its present location and condition.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20262025
Average number of employees during the year89
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 25263,000263,000
At 31 March 26263,000263,000
Amortisation and impairment
At 01 April 25170,950170,950
At 31 March 26170,950170,950
Net book value
At 31 March 2692,05092,050
At 31 March 2592,05092,050
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Total

£££
Cost or valuation
At 01 April 2524,82524,37649,201
Additions7,1787997,977
Disposals-(1,458)(1,458)
At 31 March 2632,00323,71755,720
Depreciation and impairment
At 01 April 2513,13117,41930,550
Charge for year2,8311,8604,691
On disposals-(1,144)(1,144)
At 31 March 2615,96218,13534,097
Net book value
At 31 March 2616,0415,58221,623
At 31 March 2511,6946,95718,651
5.Stocks

2026

2025

££
Raw materials and consumables1,7801,780
Total1,7801,780
6.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables1,056506
Other debtors18,51939,849
Prepayments and accrued income1,4881,343
Total21,06341,698
7.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables14,89020,428
Bank borrowings and overdrafts7,51710,000
Taxation and social security30,96464,164
Other creditors-905
Accrued liabilities and deferred income7,7883,068
Total61,15998,565
8.Creditors: amounts due after one year

2026

2025

££
Bank borrowings and overdrafts-7,538
Total-7,538
9.Related party transactions
During the year the company operated a director's loan. This balance is shown within other debtors. Interest was charged on the loan balance on a monthly basis at the UK market rate. At the year end the balance of this account was an overdrawn amount of -£14,016 (2025: -£39,849). The director has confirmed that the outstanding balance will be repaid back into the company within 9 months. This loan is repayable upon demand.